Comparer des méthodes

	Indice de Harvey-Bradshaw	Questionnaire abrégé sur les maladies inflammatoires de l'intestin
Domaine	Gastro-entérologie	Gastro-entérologie
Famille	Process / pipeline	Process / pipeline
Année d'origine	1980	2004
Auteur d'origine	R. F. Harvey and J. M. Bradshaw	Guyonnet, D., Chassany, O., Ducroc, R., et al.
Type	Clinician-rated	Self-report
Source fondatrice	Harvey, R. F., & Bradshaw, J. M. (1980). A simple index of Crohn's-disease activity. Lancet, 315(8167), 514.	Guyonnet, D., Chassany, O., Ducroc, R., Picard, C., Mouret, M., D'Haens, G., & Svartz, H. (2004). Effect of fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in France: A multicentre, randomized, double-blind, controlled trial. Alimentary Pharmacology & Therapeutics, 20(4), 459–465.
Alias	HBI	IBDQ-32, Short IBDQ
Apparentées	5	4
Résumé	The Harvey-Bradshaw Index (HBI) is a simple, clinician-administered tool for assessing disease activity in Crohn's disease. Developed in 1980, it measures five clinical parameters including abdominal pain, stool frequency, and extraintestinal manifestations. The HBI is widely used in clinical practice and research for monitoring disease progression and treatment response.	The Short Inflammatory Bowel Disease Questionnaire (IBDQ-32) is a validated patient-reported outcome measure designed to assess the impact of inflammatory bowel disease (IBD)—both ulcerative colitis and Crohn's disease—on health-related quality of life. Derived from the original 32-item IBDQ, this instrument comprises four domains: Bowel Symptoms, Systemic Symptoms, Social Function, and Emotional Function. The IBDQ-32 is responsive to treatment and is increasingly used in IBD clinical trials and practice.